Vancomycin Plus Piperacillin-Tazobactam Increases AKI Risk in ICU Patients
Researchers assessed the effects of different empiric antibiotic regimens on the risk for acute kidney injury among patients admitted to the intensive care unit.
Diagnosis & Disease Information
Is It a Penicillin Allergy or Not? An Educational Pilot Program for Health Care Providers
Unnecessary use of alternative antibiotics in patients with suspected penicillin allergy is associated with increased risk of antibiotic resistance.
Overdiagnosis of Penicillin Allergy
Nikki Kean discusses why separating penicillin allergy from a drug hypersensitivity reaction is essential to optimizing patient outcomes and reducing drug-resistant infections.
Penicillin Allergies Remain in Pharmacy Records Despite De-Labeling
Patients who have their penicillin allergy de-labeled continue to experience issues accessing penicillin when their records with their pharmacy are not up-to-date.
How the COVID-19 Pandemic Altered the Course of Antimicrobial Resistance
Anne Meneghetti, MD, discusses the effects of the COVID-19 pandemic on inappropriate antibiotic use in both the inpatient and outpatient setting.
Amoxicillin Remains Most Effective First-Line Treatment for Acute Otitis Media
Researchers compared the effects of amoxicillin with other broad-spectrum antibiotics on the risk for treatment failure and reinfection in children with uncomplicated acute otitis media.
Appendectomy vs Antibiotics: Which Is Best for Acute Appendicitis?
Is appendectomy for uncomplicated acute appendicitis in adult patients necessary or are antibiotics enough?
Inappropriate Antibiotic Prescribing for Uncomplicated Cystitis Still Occurs
Urologists appear more likely than other specialists to inappropriately treat uncomplicated cystitis with antibiotics, according to study findings.
Workflow Protocol Improves UTI Care in Older Adults
The implementation of a standardized workflow for the diagnosis and management of urinary tract infections improved care in homebound older adults.
Antibiotic Treatment Could Be CAPped at 5 Days in Children
It is common to treat community-acquired pneumonia in children with 10 days of high-dose amoxicillin; however, data from the Short-Course Antimicrobial Therapy for Pediatric Community-Acquired Pneumonia (SAFER) trial suggest that 5 days may be adequate.
- Loading...
Loading...
Next post in Evidence-Based Medicine
Loading... 
Loading...